ABOS

Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)

About Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Details

Daily high
$0.22
Daily low
$0.19
Price at open
$0.22
52 Week High
$3.60
52 Week Low
$0.19
Market cap
15.6M
Dividend yield
-
Volume
177,503
Avg. volume
6.4M
P/E ratio
-.14

Acumen Pharmaceuticals, Inc. - Common Stock News

Details

Daily high
$0.22
Daily low
$0.19
Price at open
$0.22
52 Week High
$3.60
52 Week Low
$0.19
Market cap
15.6M
Dividend yield
-
Volume
177,503
Avg. volume
6.4M
P/E ratio
-.14